このエントリーをはてなブックマークに追加
ID 48992
フルテキストURL
Thumnail 124_197.pdf 1.83 MB
タイトル(別表記)
Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by downregulating Th1 and Th17
著者
西森 久和 岡山大学大学院医歯薬学総合研究科 血液・腫瘍・呼吸器内科学
前田 嘉信 岡山大学大学院医歯薬学総合研究科 血液・腫瘍・呼吸器内科学
谷本 光音 岡山大学大学院医歯薬学総合研究科 血液・腫瘍・呼吸器内科学
キーワード
慢性移植片対宿主病
同種造血幹細胞移植
Th17細胞
Th1細胞
Am80
備考
平成23年度岡山医学会賞(林原賞)受賞論文 (The 2011 Okayama Medical Association Award)
発行日
2012-12-03
出版物タイトル
岡山医学会雑誌
出版物タイトル(別表記)
Journal of Okayama Medical Association
124巻
3号
出版者
岡山医学会
出版者(別表記)
Okayama Medical Association
開始ページ
197
終了ページ
201
ISSN
0030-1558
NCID
AN00032489
資料タイプ
学術雑誌論文
関連URL
http://www.okayama-u.ac.jp/user/oma/
参考文献
1) Nishimori H, Maeda Y, Teshima T, Sugiyama H, Kobayashi K, Yamasuji Y, Kadohisa S, Uryu H, Takeuchi K, Tanaka T, Yoshino T, Iwakura Y, et al. : Synthetic retinoid Am80 ameliorates chronic graft-versus-host disease by down-regulating Th1 and Th17. Blood (2012) 119, 285-295.
2) Ferrara JL, Levine JE, Reddy P, Holler E : Graft-versus-host disease. Lancet (2009) 373, 1550-1561.
3) Ferrara JL, Antin JH : The pathophysiology of graft-vs-host disease ; in Thomas' Hematopoietic Cell Transplantation, Blume KG, Forman SJ, Appelbaum FR (eds), Blackwell, Malden (2004) pp353-368.
4) Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, Weaver CT : Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 6, 1123-1132.
5) Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, Wang Y, Hood L, Zhu Z, Tian Q, Dong C : A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol (2005) 6, 1133-1141.
6) Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, Schluns K, Tian Q, Watowich SS, Jetten AM, Dong C : Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature (2007) 448, 480-483.
7) Ahern PP, Schiering C, Buonocore S, McGeachy MJ, Cua DJ, Maloy KJ, Powrie F : Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity (2010) 33, 279-288.
8) Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR : The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell (2006) 126, 1121-1133.
9) Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, Levy DE, Leonard WJ, Littman DR : IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol (2007) 8, 967-974.
10) Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, Dong C : STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem (2007) 282, 9358-9363.
11) Yang XO, Pappu BP, Nurieva R, Akimzhanov A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS, Watowich SS, Tian Q, et al. : T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity (2008) 28, 29-39.
12) Yi T, Chen Y, Wang L, Du G, Huang D, Zhao D, Johnston H, Young J, Todorov I, Umetsu DT, Chen L, Iwakura Y, et al. : Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood (2009) 114, 3101-3112.
13) Yi T, Zhao D, Lin CL, Zhang C, Chen Y, Todorov I, LeBon T, Kandeel F, Forman S, Zeng D : Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease. Blood (2008) 112, 2101-2110.
14) Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, Holland AM, Grubin J, Mark NM, Liu C, Iwakura Y, Heller G, et al. : IL-17 contributes to CD4-mediated graft-versus-host disease. Blood (2009) 113, 945-952.
15) Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS : In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease
with severe cutaneous and pulmonary pathologic manifestations. Blood (2009) 113, 1365-1374.
16) Via CS : Kinetics of T cell activation in acute and chronic forms of murine graft-versus-host disease. J Immunol (1991) 146, 2603-2609.
17) Hashimoto Y, Shudo K : Retinoids and their nuclear receptors. Cell Biol Rev (1991) 25, 209-235.
18) Hashimoto Y : Retinobenzoic acids and nuclear retinoic acid receptors. Cell Struct Funct (1991) 16, 113-123.
19) Nagai H, Matsuura S, Bouda K, Takaoka Y, Wang T, Niwa S, Shudo K : Effect of Am-80, a synthetic derivative of retinoid, on experimental arthritis in mice. Pharmacology (1999) 58, 101-112.
20) Hashimoto Y, Kagechika H, Kawachi E, Fukasawa H, Saito G, Shudo K : Correlation of differentiation-inducing activity of retinoids on human leukemia cell lines HL-60 and NB4. J Cancer Res Clin Oncol (1995) 121, 696-698.
21) Kagechika H, Kawachi E, Hashimoto Y, Himi T, Shudo K : Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity. J Med Chem (1988) 31, 2182-2192.
22) Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H : Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science (2007) 317, 256-260.
言語
Japanese
著作権者
Copyright (c) 2012 岡山医学会
論文のバージョン
publisher
査読
有り
DOI
Eprints Journal Name
joma